Epidemiological blood pressure (BP) surveys suggest that BP determinations are often subject to considerable within-visit variation. For this reason, a memorandum from a WHO/ISH meeting published in 1983 1 stressed that BP should be measured at least three times over a period of at least 3 minutes at each visit and the lowest reading should be recorded. The same committee has now recommended that two or more measurements should be taken over the same interval and the mean value should be used.
1
stressed that BP should be measured at least three times over a period of at least 3 minutes at each visit and the lowest reading should be recorded. The same committee has now recommended that two or more measurements should be taken over the same interval and the mean value should be used. 2 The scientific basis for this slight change in the recommendation has not been fully explained. The present study was performed to obtain information on the magnitude and time course of the variability in casual BP measurements recorded for individual patients during routine clinical practice that would be useful in determining the desirable number of BP readings in outpatient clinic settings.
Patients with a history of hypertension (systolic BP> 160mmHgordiastolic BP>90mmHg, or both) were recruited consecutively from our outpatient clinic. The study subjects consisted of 63 patients (38 men and 25 women) aged 63 ± 11 (SD) years, 46 of whom were undergoing antihypertensive therapy. Seventyeight percent of patients had end-organ damage, as evidenced by Grade II and HI retinopathy or left ventricular hypertrophy, or both.
BP and heart rate (HR) were recorded in the sitting position by nurses using an automatic blood pressure recorder (Model BP103-N; Nippon Kohrin, Komaki, Japan) throughout to eliminate observer error.
3 This device determines the systolic, mean, and diastolic BPs based on an orderly sequence of oscillations in cuff pressure. 4 The device was set to inflate automatically every minute. Each patient had four consecutive BP measurements at each visit, and the examination was repeated four times in an identical manner at 2-or 4-week intervals. Figure 1 shows the mean differences between the individual values and the average of four serial readings at each visit for a total of 252 (63 patients X 4 visits) BP and HR measurements. They were significantly different from each other when tested by oneway analysis of variance (p<0.0001). As seen in Figure 1 , systolic, mean, and diastolic BP levels progressively decreased during multiple readings. The mean value of the fourth reading was lower than that of the first by 4.3, 2.3, and 1.9 mm Hg, respectively. The differences between the mean values of the first two readings and those of the last two readings were statistically significant, while the differences between each of the last two readings were not significant. For systolic and mean, but not diastolic, BP the differences between each of the first two readings were also insignificant. Finally, the HR obtained in the first reading was significantly higher than that of successive readings. The mean value of the second reading was lower than that of the first one by 2.5 beats/min.
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